OBJECTIVE: To evaluate serum interferon-α (IFNα) activity in the context of autoantibody profiles in patients with juvenile dermatomyositis (JDM). METHODS: Sera from 36 patients with JDM were analyzed. Autoantibody profiles were determined by probing microarrays, which were fabricated with ∼80 distinct autoantigens, with serum and a Cy3-conjugated secondary antibody. Arrays were scanned and analyzed to determine antigen reactivity. Serum IFNα activity was measured using a functional reporter cell assay. Sera were assayed alone or in combination with cellular material released from necrotic U937 cells to stimulate peripheral blood mononuclear cells from healthy donors in vitro, and IFNα production in culture was measured by a dissociation-enhanced lanthanide fluoroimmunoassay (DELFIA). RESULTS: Reactivity against at least 1 of 41 autoantigens on the microarray, including Ro 52, Ro 60, La, Sm, and RNP, was observed in 75% of the serum samples from patients with JDM. IFNα activity was detected in 7 samples by reporter cell assay. The reporter cell assay showed a significant association of reactivity against Ro, La, Sm, and proliferating cell nuclear antigen with serum IFNα activity (P = 0.005). Significance Analysis of Microarrays (SAM) identified increased reactivity against Sm, RNP, Ro 52, U1-C, and Mi-2 in these sera. Sixteen samples induced IFNα production as measured by DELFIA, and there was a significant association of reactivity against Ro, La, Sm, and RNP with the induction of IFNα by serum and necrotic cell material (P = 0.034). SAM identified increased reactivity against Ro 60 in these sera. CONCLUSION: These data support the hypothesis that nucleic acid-associated autoantibodies, including the Ro/La and Sm/RNP complexes, may stimulate the production of active IFNα in children with JDM.
OBJECTIVE: To evaluate serum interferon-α (IFNα) activity in the context of autoantibody profiles in patients with juvenile dermatomyositis (JDM). METHODS: Sera from 36 patients with JDM were analyzed. Autoantibody profiles were determined by probing microarrays, which were fabricated with ∼80 distinct autoantigens, with serum and a Cy3-conjugated secondary antibody. Arrays were scanned and analyzed to determine antigen reactivity. Serum IFNα activity was measured using a functional reporter cell assay. Sera were assayed alone or in combination with cellular material released from necroticU937 cells to stimulate peripheral blood mononuclear cells from healthy donors in vitro, and IFNα production in culture was measured by a dissociation-enhanced lanthanide fluoroimmunoassay (DELFIA). RESULTS: Reactivity against at least 1 of 41 autoantigens on the microarray, including Ro 52, Ro 60, La, Sm, and RNP, was observed in 75% of the serum samples from patients with JDM. IFNα activity was detected in 7 samples by reporter cell assay. The reporter cell assay showed a significant association of reactivity against Ro, La, Sm, and proliferating cell nuclear antigen with serum IFNα activity (P = 0.005). Significance Analysis of Microarrays (SAM) identified increased reactivity against Sm, RNP, Ro 52, U1-C, and Mi-2 in these sera. Sixteen samples induced IFNα production as measured by DELFIA, and there was a significant association of reactivity against Ro, La, Sm, and RNP with the induction of IFNα by serum and necrotic cell material (P = 0.034). SAM identified increased reactivity against Ro 60 in these sera. CONCLUSION: These data support the hypothesis that nucleic acid-associated autoantibodies, including the Ro/La and Sm/RNP complexes, may stimulate the production of active IFNα in children with JDM.
Authors: Imelda Balboni; Steven M Chan; Michael Kattah; Jessica D Tenenbaum; Atul J Butte; Paul J Utz Journal: Annu Rev Immunol Date: 2006 Impact factor: 28.527
Authors: William H Robinson; Carla DiGennaro; Wolfgang Hueber; Brian B Haab; Makoto Kamachi; Erik J Dean; Sylvie Fournel; Derek Fong; Mark C Genovese; Henry E Neuman de Vegvar; Karl Skriner; David L Hirschberg; Robert I Morris; Sylviane Muller; Ger J Pruijn; Walther J van Venrooij; Josef S Smolen; Patrick O Brown; Lawrence Steinman; Paul J Utz Journal: Nat Med Date: 2002-03 Impact factor: 53.440
Authors: Zivana Tezak; Eric P Hoffman; Jennica L Lutz; Tamara O Fedczyna; Dietrich Stephan; Eric G Bremer; Irina Krasnoselska-Riz; Ajit Kumar; Lauren M Pachman Journal: J Immunol Date: 2002-04-15 Impact factor: 5.422
Authors: L M Pachman; J M Friedman; M L Maryjowski-Sweeney; O Jonnason; R M Radvany; G C Sharp; M A Cobb; N D Battles; W E Crowe; C W Fink Journal: Arthritis Rheum Date: 1985-02
Authors: Tiffany Perkins; Jacob M Rosenberg; Carole Le Coz; Joseph T Alaimo; Melissa Trofa; Sureni V Mullegama; Richard J Antaya; Soma Jyonouchi; Sarah H Elsea; Paul J Utz; Eric Meffre; Neil Romberg Journal: J Allergy Clin Immunol Pract Date: 2017-03-09
Authors: Theresa Wampler Muskardin; Priyanka Vashisht; Jessica M Dorschner; Mark A Jensen; Beverly S Chrabot; Marlena Kern; Jeffrey R Curtis; Maria I Danila; Stacey S Cofield; Nancy Shadick; Peter A Nigrovic; E William St Clair; Clifton O Bingham; Richard Furie; William Robinson; Mark Genovese; Christopher C Striebich; James R O'Dell; Geoffrey M Thiele; Larry W Moreland; Marc Levesque; S Louis Bridges; Peter K Gregersen; Timothy B Niewold Journal: Ann Rheum Dis Date: 2015-11-06 Impact factor: 19.103
Authors: D James Haddon; Vivian K Diep; Jordan V Price; Cindy Limb; Paul J Utz; Imelda Balboni Journal: Arthritis Res Ther Date: 2015-06-17 Impact factor: 5.156